2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Heterogeneity of Treatment Effects of Adding Locoregional Therapies to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma (ISMIO-026)Unresectable Hepatocellular CarcinomaNot yet recruitingNot stated2026-09-17NCT07824765
AI Assistance for Detecting Active Bleeding During DSA ProceduresHemorrhage, Pathologic Processes, Pathological Conditions, Signs and SymptomsNot yet recruitingNot applicable2026-09-17NCT07824739